LENZ Therapeutics, Inc. (LENZ)
10.06
+0.34
(+3.50%)
USD |
NASDAQ |
May 08, 16:00
10.10
+0.04
(+0.40%)
After-Hours: 20:00
LENZ Therapeutics Enterprise Value : 23.89M for May 8, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Maze Therapeutics, Inc. | 975.31M |
| CDT Equity, Inc. | 9.007M |
| Liminatus Pharma, Inc. | 10.21M |
| Oruka Therapeutics, Inc. | 2.868B |
| MapLight Therapeutics, Inc. | 863.45M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -35.90M |
| Revenue (Quarterly) | 1.588M |
| Total Expenses (Quarterly) | 37.48M |
| EPS Diluted (Quarterly) | -1.155 |
| Gross Profit Margin (Quarterly) | 66.94% |
| Profit Margin (Quarterly) | -2.26K% |
| Earnings Yield | -27.86% |
| Normalized Earnings Yield | -27.86 |